IL22 and psoriasis: Their study revealed that the topical application of compound 3 (2 mM) significantly ameliorated hyperplasia and inflammatory cell infiltration and suppressed the expression of the psoriasis-associated genes S100a9, Krt1, Il17a, and Il22.